Retatrutide 5 mg (Lyophilized Powder) – Next-Generation Multi-Agonist for Comprehensive Metabolic Support
Retatrutide 5 mg is a lyophilized (freeze-dried) powder designed for reconstitution and administration under the direction of qualified healthcare professionals. As a cutting-edge triple agonist (GLP-1, GIP, and glucagon receptors), Retatrutide represents a new class of therapies targeting multiple pathways involved in appetite regulation, energy expenditure, and glucose metabolism.
This 5 mg formulation offers a flexible option for those beginning treatment or seeking customised dosing strategies.
 
Key Features:
5 mg of Retatrutide per vial (not reconstituted)
Triple receptor agonist: GLP-1, GIP, and Glucagon
Promotes significant fat loss, improved glycemic control, and enhanced metabolic efficiency
Designed for clinical compounding and individualized protocols
Ideal for early-stage or lower-dose treatment strategies
 
Usage Note:
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or per provider instruction. Intended for sterile use under medical supervision. Appropriate training and guidance are recommended for preparation and administration.
 
FOR RESEARCH PURPOSES ONLY.